Next Financial Group’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
Next Financial Group's XLRN Position: Q4 2021 in Review
Next Financial Group sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 3 shares — an estimated $1K sold.
Next Financial Group first reported a position in XLRN in Q3 2020 and held it in 5 quarters. The position peaked at $1K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Next Financial Group reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Next Financial Group sold 3 Acceleron Pharma shares in Q4 2021, an estimated $1K.
- Next Financial Group first reported a position in Acceleron Pharma in Q3 2020 and held it in 5 quarters.
- Next Financial Group's Acceleron Pharma position peaked at $1K in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.